Thilorbin eye drops
Replacement
|
Medicines
|
17/12/2013
WABOSAN Arzneimittelvertriebs GmbH has informed its supplied customers by letter dated 12.12.2013 that yellow-orange precipitations have been observed in batch Y260 in individual cases and therefore a precautionary recall is being carried out. This medicinal product is approved in Germany and is placed on the market in Austria within the scope of a transfer notification pursuant to the Austrian Medicinal Products Import Act 2010.
Name of the medicinal product | Thilorbin |
---|---|
Marketing authorisation number(s) | DE-Zulassungsnummer: 6176696.00.00 |
Marketing authorisation holder | OmniVision GmbH Antragsteller Verbringungsmeldung: WABOSAN Arzneimittelvertriebs GmbH |
Batch number(s) | Y260 |
Classification of the recall | 2 |
BASG reference number | INS-640.001-0900 |
Further inquiry note
Page last modified:
12/07/2022